Clinical Trials Logo
  1. Home
  2. Male Hypogonadism
  3. NCT02081300

Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism — SOAR  

Male Hypogonadism Clinical Trial

Official title:
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men

Clinical Trial Summary

The purpose of this study is to determine the safety and efficacy of an oral testosterone undecanoate formulation for use as testosterone-replacement therapy in men with low testosterone.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02081300
Study type Interventional
Source Lipocine Inc.
Contact
Status Completed
Phase Phase 3
Start date February 2014
Completion date May 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT01446042 - Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism Phase 3
Completed NCT02966652 - Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism Phase 1
Completed NCT01228071 - Time to Eugonadal Range, Time to Steady State and Drying Time Phase 3
Withdrawn NCT02715713 - Autonomic Manifestations of Testosterone Deficiency in Men N/A
Completed NCT00858650 - Registry of Hypogonadism in Men N/A
Recruiting NCT05541172 - Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism
Not yet recruiting NCT04704141 - Relationship of the Microenvironment and Male Fertility
Completed NCT01403116 - Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men Phase 3
Completed NCT00924612 - Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation Phase 2
Completed NCT00911586 - Pharmacokinetic Study to Determine Time to Steady-state Phase 2
Completed NCT01765179 - Safety and Efficacy Trial of Testosterone Undecanoate Phase 3
Completed NCT00475501 - 5-Alpha Reductase and Anabolic Effects of Testosterone Phase 2
Completed NCT04708249 - D-chiroinositol Administration in Hypogonadal Males N/A
Active, not recruiting NCT03721497 - Testosterone in Bariatric Patients Phase 4
Completed NCT01699178 - Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men Phase 3